TABLE 5.
The roles of miR-100-5p in lung disease.
| Author | Disease | Target/pathway | Role | Expression | Reference |
|---|---|---|---|---|---|
| Wang | Hypoxic pulmonary hypertension | mTOR | Regulate the proliferation of pulmonary artery smooth muscle cells | — | Wang et al. (2015) |
| Ye | Amyloid ß-induced neuronal pathologies | mTOR pathway | Promote cell apoptosis and affect cell survival | — | Ye et al. (2015) |
| Frith | — | mTOR pathway | Modulate MSC fate | Frith et al. (2018) | |
| Liu; Peng | PF and liver fibrosis | — | — | ↑ | Peng et al. (2016); Liu et al. (2018) |
| Wu | Osteoarthritis | mTOR | Provide a protective effect on articular cartilage and inhibit cell apoptosis | — | Wu et al. (2019) |
| Dinh | Exosomes from lung spheroid cells | — | — | ↑ | Dinh et al. (2020) |
| Wang | MSCs and chronic PM2.5 exposure | — | — | ↑ | Wang Y. et al. (2021) |
| Wang | — | — | Inhibit hypoxia-induced proliferation, migration, and phenotype switching of pulmonary artery smooth muscle cells | — | Wang et al. (2020) |